Literature DB >> 8854166

Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate.

T M Tallab1, K A Bahamdam, S Mirdad, H Johargi, M M Mourad, K Ibrahim, A H el Sherbini, E Karkashan, A K Khare, A Jamal.   

Abstract

BACKGROUND: Various therapeutic modalities have been used for treating cutaneous leishmaniasis. Intralesional pentavalent antimonial injection is one of the effective therapeutic modalities. In this study, the efficacy of three different intralesional schedules with sodium stibogluconate have been investigated.
METHODS: Ninety-six patients with 129 lesions were entered into the study, all with confirmed diagnosis of cutaneous leishmaniasis. The lesions were treated with three different schedules, including daily, alternate day, and weekly interlesional injections of sodium stibogluconate. The clinical response was then compared to arrive at the most effective schedule.
RESULTS: The clinical responses (complete and partial cure) were 67%, 97%, and 91% for the daily, alternate-day, and weekly schedules, respectively. Lesions with either partial cure or failure of treatment were injected weekly with the same medication until complete cure had been achieved. The final overall success rate of complete cure was 99.2%.
CONCLUSIONS: Alternate day or weekly intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate are more effective than daily treatments.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8854166     DOI: 10.1111/j.1365-4362.1996.tb03669.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  13 in total

Review 1.  Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis.

Authors:  Begoña Monge-Maillo; Rogelio López-Vélez
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

Review 2.  An update on pharmacotherapy for leishmaniasis.

Authors:  Shyam Sundar; Jaya Chakravarty
Journal:  Expert Opin Pharmacother       Date:  2014-10-25       Impact factor: 3.889

3.  Systemic meglumine antimoniate in acute cutaneous leishmaniasis: children versus adults.

Authors:  Pouran Layegh; Sara Rahsepar; Amir Ali Rahsepar
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

4.  Intralesional meglumine antimoniate for treatment of cutaneous leishmaniasis patients with contraindication to systemic therapy from Rio de Janeiro (2000 to 2006).

Authors:  Erica de Camargo Ferreira E Vasconcellos; Maria Inês Fernandes Pimentel; Armando de Oliveira Schubach; Raquel de Vasconcellos Carvalhaes de Oliveira; Rilza Beatriz Azeredo-Coutinho; Fátima da Conceição Silva; Mariza de Matos Salgueiro; João Soares Moreira; Maria de Fátima Madeira; Cibele Baptista; Cláudia Maria Valete-Rosalino
Journal:  Am J Trop Med Hyg       Date:  2012-08       Impact factor: 2.345

5.  Leishmaniasis of the lip diagnosed by lymph node aspiration and treated with a combination of oral ketaconazole and intralesional sodium stibogluconate.

Authors:  Biju Vasudevan; Ashish Bahal
Journal:  Indian J Dermatol       Date:  2011-03       Impact factor: 1.494

6.  Treating cutaneous leishmaniasis patients in Kabul, Afghanistan: cost-effectiveness of an operational program in a complex emergency setting.

Authors:  Richard Reithinger; Paul G Coleman
Journal:  BMC Infect Dis       Date:  2007-01-30       Impact factor: 3.090

Review 7.  Cutaneous Leishmaniasis in Saudi Arabia: A Comprehensive Overview.

Authors:  Abuzaid A Abuzaid; Abdalmohsin M Abdoon; Mohamed A Aldahan; Abdullah G Alzahrani; Raaft F Alhakeem; Abdullah M Asiri; Mohamed H Alzahrani; Ziad A Memish
Journal:  Vector Borne Zoonotic Dis       Date:  2017-08-14       Impact factor: 2.133

8.  Evaluation of the Interventional Approaches in the Management of Cutaneous Leishmaniasis in Jazan: An Observational Study.

Authors:  Hafiz A Makeen; Mohammed A Buraik; Santhosh Joseph Menachery; Khalid M Alattas; Abdulkarim M Meraya
Journal:  Ann Dermatol       Date:  2018-08-28       Impact factor: 1.444

9.  Efficacy of intralesional amphotericin B for the treatment of cutaneous leishmaniasis.

Authors:  Vahid Mashayekhi Goyonlo; Elham Vosoughi; Bita Kiafar; Yalda Nahidi; Akram Momenzadeh; Ahmad Reza Taheri
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

10.  Efficacy of cryotherapy plus topical Juniperus excelsa M. Bieb cream versus cryotherapy plus placebo in the treatment of Old World cutaneous leishmaniasis: A triple-blind randomized controlled clinical trial.

Authors:  Mohammad Mahdi Parvizi; Farhad Handjani; Mahmoodreza Moein; Gholamreza Hatam; Majid Nimrouzi; Jafar Hassanzadeh; Nasrin Hamidizadeh; Hamid Reza Khorrami; Mohammad Mehdi Zarshenas
Journal:  PLoS Negl Trop Dis       Date:  2017-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.